THE ROLE OF TP53 MUTATIONS IN LOW-RISK MDS PATIENTS

被引：0
|
作者：
Belickova, M. [1 ]
Vesela, J. [1 ]
Jonasova, A. [2 ]
Kohlmann, A. [3 ]
Stara, E. [1 ]
Planetova, B. [1 ]
Valka, J. [1 ]
Zemanova, Z. [2 ]
Brezinova, J. [1 ]
Michalova, K. [1 ,2 ]
Cermak, J. [1 ]
机构：
[1] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic
[2] Gen Univ Hosp, Prague, Czech Republic
[3] Munich Leukemia Lab, Munich, Germany
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P320
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [21] The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases
    Stengel, A.
    Kern, W.
    Haferlach, T.
    Meggendorfer, M.
    Fasan, A.
    Haferlach, C.
    LEUKEMIA, 2017, 31 (03) : 705 - 711
  • [22] 17P DELETIONS AND TP53 MUTATIONS IN PATIENTS WITH MDS/AML AND COMPLEX ABERRANT KARYOTYPE
    Schaab, R.
    Ganster, C.
    Dierks, S.
    Parra, M. Tallo
    Martin, R.
    Germing, U.
    Platzbecker, U.
    Shirneshan, K.
    Lange, F.
    Kroeger, N.
    Doehner, K.
    Glass, B.
    Bacher, U.
    Haase, D.
    HAEMATOLOGICA, 2016, 101 : 68 - 68
  • [23] Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations
    Ciurea, Stefan O.
    Chilkulwar, Abhishek
    Saliba, Rima M.
    Chen, Julianne
    Rondon, Gabriela
    Patel, Keyur P.
    Khogeer, Haitham
    Shah, Abdul R.
    Randolph, Brion V.
    Perez, Jorge M. Ramos
    Popat, Uday
    Hosing, Chitra M.
    Bashir, Qaiser
    Mehta, Rohtesh
    Al-Atrash, Gheath
    Im, Jin
    Khouri, Issa F.
    Kebriaei, Partow
    Champlin, Richard E.
    BLOOD, 2018, 131 (26) : 2989 - 2992
  • [24] High frequency of TP53 mutations in juvenile pilocytic astrocytomas indicates role of TP53 in the development of these tumors
    Hayes, VM
    Dirven, CMF
    Dam, A
    Verlind, E
    Molenaar, WM
    Mooij, JJA
    Hofstra, RMW
    Buys, CHCM
    BRAIN PATHOLOGY, 1999, 9 (03) : 463 - 467
  • [25] TP53 mutations in Romanian patients with colorectal cancer
    Felix Manirakiza
    Hidetaka Yamada
    Yuji Iwashita
    Keiko Ishino
    Rei Ishikawa
    Zsolt Kovacs
    Eva Osvath
    Augustin Nzitakera
    Simona Gurzu
    Haruhiko Sugimura
    Genes and Environment, 45
  • [26] Surveillance recommendations for patients with germline TP53 mutations
    Ballinger, Mandy L.
    Mitchell, Gillian
    Thomas, David M.
    CURRENT OPINION IN ONCOLOGY, 2015, 27 (04) : 332 - 337
  • [27] TP53 mutations in Romanian patients with colorectal cancer
    Manirakiza, Felix
    Yamada, Hidetaka
    Iwashita, Yuji
    Ishino, Keiko
    Ishikawa, Rei
    Kovacs, Zsolt
    Osvath, Eva
    Nzitakera, Augustin
    Gurzu, Simona
    Sugimura, Haruhiko
    GENES AND ENVIRONMENT, 2023, 45 (01)
  • [28] CN-LOH plays a critical Role for the Determination of TP53 Allele Status and Risk Stratification in MDS Patients
    Meggendorfer, M.
    Walter, W.
    Kern, W.
    Haferlach, T.
    Haferlach, C.
    Stengel, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 35 - 35
  • [29] Incidence and prognostic value of TP53 mutations in IPSS low and INT 1 (lower risk) MDS with del 5q
    Bally, C.
    Ades, L.
    Renneville, A.
    Preudhomme, C.
    Raynaud, S.
    Cluzeau, T.
    Eclache, V.
    Hunault-Berger, M.
    Stamoullas, A.
    Fontenay, M.
    Mozziconacci, M. J.
    De The, H.
    Fenaux, P.
    Lehmann-Che, J.
    LEUKEMIA RESEARCH, 2013, 37 : S32 - S33
  • [30] TP53 mutations in favorable risk WNT subtype medulloblastomas
    Hill, Rebecca M.
    Lindsey, Janet C.
    Megahed, Hisham
    Schwalbe, Ed C.
    Cole, Michael
    Hogg, Twala L.
    Gilbertson, Richard J.
    Ellison, David W.
    Bailey, Simon
    Clifford, Steven C.
    CANCER RESEARCH, 2011, 71
12345